First Time Loading...

Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 572.71 USD -1.32% Market Closed
Updated: May 9, 2024
Section:
 

Relative Value

The Relative Value of one CHE stock under the Base Case scenario is 600.08 USD. Compared to the current market price of 572.71 USD, Chemed Corp is Undervalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CHE Relative Value
Base Case
600.08 USD
Undervaluation 5%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.8
P/S
P/S
Price to Sales
3.8
vs History
12
vs Industry
34
Median 3Y
3.6
Median 5Y
3.6
Industry
2.4
Forward
3.5
More Details
30.6
P/E
P/E
Price to Earnings
30.6
vs History
33
vs Industry
19
Median 3Y
29.2
Median 5Y
28.9
Industry
23.4
Forward
24.2
More Details
24.5
P/OCF
P/OCF
Price to OCF
24.5
vs History
22
vs Industry
17
Median 3Y
23.9
Median 5Y
22.5
Industry
15.5
More Details
29
P/FCFE
P/FCFE
Price to FCFE
29
vs History
30
vs Industry
20
Median 3Y
26.7
Median 5Y
26.7
Industry
23.2
More Details
7.3
P/B
P/B
Price to Book Value
7.3
vs History
96
vs Industry
10
Median 3Y
9
Median 5Y
9.3
Industry
2.3
More Details
3.6
EV/S
EV/S
Enterprise Value to Sales
3.6
vs History
23
vs Industry
32
Median 3Y
3.5
Median 5Y
3.6
Industry
2.5
Forward
3.4
More Details
10.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.3
vs History
46
vs Industry
22
Median 3Y
10
Median 5Y
10.2
Industry
5.3
More Details
19.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.2
vs History
50
vs Industry
18
Median 3Y
18.7
Median 5Y
19.5
Industry
12.6
Forward
16.1
More Details
22.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.4
vs History
49
vs Industry
22
Median 3Y
21.9
Median 5Y
22.7
Industry
17.2
Forward
19.3
More Details
23.6
EV/OCF
EV/OCF
Enterprise Value to OCF
23.6
vs History
31
vs Industry
19
Median 3Y
23.7
Median 5Y
22.5
Industry
15.3
More Details
27.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.6
vs History
46
vs Industry
19
Median 3Y
29.5
Median 5Y
27.5
Industry
19.8
More Details
6.2
EV/IC
EV/IC
Enterprise Value to IC
6.2
vs History
19
vs Industry
15
Median 3Y
6
Median 5Y
6
Industry
2
More Details

Multiples Across Competitors

CHE Competitors Multiples
Chemed Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Chemed Corp
NYSE:CHE
8.7B USD 3.8 30.6 19.2 22.4
US
Cigna Corp
NYSE:CI
98.5B USD 0.5 27.2 9.8 13
US
Cigna Group
XMUN:CGN
91.3B EUR 0.5 27.1 9.8 12.9
US
CVS Health Corp
NYSE:CVS
69B USD 0.2 9.4 8.6 8.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
16B EUR 0.7 -27 10.2 22.8
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD 1.4 39.1 11.9 17.9
US
Quest Diagnostics Inc
NYSE:DGX
15.2B USD 1.6 18 10.8 14.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.3B EUR 0.6 22.7 6.8 16.1
US
DaVita Inc
NYSE:DVA
11.9B USD 1 14.6 8.3 11.8
DE
Fresenius Medical Care AG
XMUN:FME
11B EUR 0.6 22 6.7 15.9
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
CHE intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHE stock valuation using valuation multiples.
Wall Street Estimates
CHE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.